Alvotech Net Income From Continuing Ops from 2010 to 2026
| ALVO Stock | USD 5.32 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -208.7 M | Current Value -219.1 M | Quarterly Volatility 113.6 M |
Check Alvotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alvotech's main balance sheet or income statement drivers, such as Tax Provision of 17.3 M, Interest Income of 5.6 M or Depreciation And Amortization of 22.9 M, as well as many indicators such as Price To Sales Ratio of 7.91, Dividend Yield of 0.0 or Days Sales Outstanding of 344. Alvotech financial statements analysis is a perfect complement when working with Alvotech Valuation or Volatility modules.
Alvotech | Net Income From Continuing Ops | Build AI portfolio with Alvotech Stock |
Evaluating Alvotech's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Alvotech's fundamental strength.
Latest Alvotech's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Alvotech over the last few years. It is Alvotech's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alvotech's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Alvotech Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (240,898,358) | |
| Coefficient Of Variation | (47.18) | |
| Mean Deviation | 68,648,739 | |
| Median | (209,876,000) | |
| Standard Deviation | 113,644,640 | |
| Sample Variance | 12915.1T | |
| Range | 450.2M | |
| R-Value | (0.30) | |
| Mean Square Error | 12570.1T | |
| R-Squared | 0.09 | |
| Significance | 0.25 | |
| Slope | (6,658,662) | |
| Total Sum of Squares | 206641.7T |
Alvotech Net Income From Continuing Ops History
About Alvotech Financial Statements
Alvotech investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Alvotech Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -208.7 M | -219.1 M |
Pair Trading with Alvotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alvotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Alvotech Stock
Moving against Alvotech Stock
| 0.64 | INCY | Incyte | PairCorr |
| 0.64 | ACW | Actinogen Medical | PairCorr |
| 0.52 | GMAB | Genmab AS | PairCorr |
| 0.48 | ENTA | Enanta Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.39 | OBIO | Orchestra BioMed Holdings | PairCorr |
The ability to find closely correlated positions to Alvotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alvotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alvotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alvotech to buy it.
The correlation of Alvotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alvotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alvotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alvotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Alvotech Correlation against competitors. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Biotechnology sector continue expanding? Could Alvotech diversify its offerings? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alvotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.58) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Understanding Alvotech requires distinguishing between market price and book value, where the latter reflects Alvotech's accounting equity. The concept of intrinsic value—what Alvotech's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alvotech's price substantially above or below its fundamental value.
Understanding that Alvotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alvotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alvotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.